Navigation Links
Seven More Plaintiffs Sue Stryker over Defective Hip Implant Devices
Date:9/11/2012

WEST PALM BEACH, Fla., Sept. 11, 2012 /PRNewswire/ -- South Florida law firm Searcy Denney Scarola Barnhart & Shipley PA (Searcy Denney) today announced that it has filed seven additional lawsuits against Howmedica Osteonics Corporation, dba Stryker Orthopaedics, over the company's Rejuvenate and ABG II hip implant systems.  

Searcy Denney filed the nation's first lawsuit over the recalled medical device in early August on behalf of a plaintiff in Boca Raton, Fla. The expanded claims against Stryker include allegations from plaintiffs in Lake Worth, Fla., Boynton Beach, Fla., Pillage, Minn., Boca Raton, Fla., St. Cloud, Minn., and two from Tucson, Ariz. All of the suits were filed in Bergen County (N.J.) Superior Court and allege that Stryker negligently developed, tested, manufactured, distributed, marketed, and sold its defective "Rejuvenate System."

"We have reached a decisive stage in this litigation as legitimate claims are now proliferating nationwide," said Cal Warriner, a shareholder at Searcy Denney who represents the eight total plaintiffs. "The Rejuvenate System has only been on the market since 2009, yet, just a few years later, an overwhelming number of patients have suffered heavy metal toxicity."

"Stryker marketed its devices as an improvement over and alternative to other metal-on-metal hip implants when in fact these systems have caused significantly more severe injuries than comparable systems on the market."

In April 2012, Stryker issued an Urgent Field Safety Notice to surgeons and hospitals, which acknowledged reports of heavy metal contamination, such as that experienced by the eight total plaintiffs. Stryker then issued a recall of the devices in Canada, followed in July by a U.S. voluntary recall of the same Rejuvenate and ABG II hip replacement systems.

"The recall is a clear admission by Stryker that its product is defective and dangerous," said Warriner.

The seven new plaintiffs were implanted with the devices between June 2009 and September 2011 and underwent corrective revision surgery in as little as eight months. In each instance, the revision surgery revealed heavy metal toxicity, including "the presence of milky, turbid fluid; large pseudotumor formation; soft tissue necrosis; muscle loss and/or bony necrosis at the proximal femur," according to the complaint.

Stryker's Rejuvenate System, which features a chrome cobalt neck and titanium stem, is marketed to patients in need of primary total hip arthroplasty or replacement, often due to painful joint diseases caused by non-inflammatory degenerative arthritis.

Thousands of Stryker victims have been notified that their recalled hip may be poisoning them and Stryker has given no assurance that it will pay to have the device removed. "I get several calls a day from distraught clients wondering if this disaster is going to bankrupt them," said Warriner. "Many simply can't afford to have it removed. Stryker has really aggravated a lot of doctors with its response to this recall. Doctors are jumping ship to other manufacturers' products because they are disgusted."

The plaintiffs seek compensatory, consortium, actual, and punitive damages. They are requesting a jury trial.

About Searcy Denney Scarola Barnhart & Shipley, PA

A nationally recognized trial law firm, Searcy Denney Scarola Barnhart & Shipley, P.A. is committed to protecting victims of negligence, defective products and corporate wrongdoing.  Over the past 35 years, the firm has represented clients in courtrooms throughout Florida and across the nation.


'/>"/>
SOURCE Searcy Denney Scarola Barnhart & Shipley PA
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Wave of Celebrity Support Boosts Global Effort to Eliminate Seven Diseases by 2020
2. Seventeenth Patient Dosed in Neuralstem ALS Stem Cell Trial
3. 3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
4. Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference
5. Pricing and Reimbursement in Russia - Big Pharma Take Advantage of Reimbursement for Costly Drugs Through the DLOs Seven Nosologies Program
6. Seventeen Banner Health facilities achieve final stage of electronic medical record adoption
7. RD Legal Funding Provides Immediate Settlement Financing to Growing Number of Yaz and Yasmin Plaintiffs
8. Problems With the Stryker Rejuvenate Hip System
9. The Gomez Law Firm Launches New Website Representing Victims Of Defective Stryker Hip Replacement Systems
10. Stryker Initiates Voluntary Product Recall of Modular-Neck Stems
11. Terso Solutions partners with Champion Medical Technologies to offer fully automated tracking of Tissue and Implantable Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... WOONSOCKET, R.I. , Feb. 10, 2016  CVS ... vaccines to people living in Santa Clara ... of Meningitis B on the Santa Clara University campus. ... vaccines available to protect patients against the disease. Students ... are encouraged to get vaccinated. In addition, anyone who ...
(Date:2/10/2016)... Feb. 10, 2016  Oxis International Inc. (OTC/QB: OXIS) ... was described as a "clinical trial triumph" after one ... into complete cancer remission. Daniel Vallera ... Masonic Cancer Center. --> Daniel Vallera ... Masonic Cancer Center. --> An article ...
(Date:2/10/2016)... 2016  LexisNexis® Risk Solutions, a leading provider ... launch of LexisNexis Provider Performance Monitor , ... and optimize the quality and efficiency of provider ... scores. By measuring provider performance through Provider Performance ... better outcomes, improve the patient experience and reduce ...
Breaking Medicine Technology:
(Date:2/10/2016)... Calif. (PRWEB) , ... February 10, 2016 , ... ... Water Brand. There were three leading bottled water brand owners that topped the list ... that enhance connectivity and optimize conversion. The premier brand was Tibet 5100, a top ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... bring together more than 200 of the country’s top healthcare executives to share ... “The true benefit of the Forum is the provider-centric perspective, experience, expertise and ...
(Date:2/10/2016)... ... ... Armune BioScience signed a definitive agreement with ARCpoint Labs ... country. Launched in April of 2015, Apifiny is the only cancer specific, non-PSA blood ... exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized Apifiny to ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... the Ohio Safety Congress and Expo event March 9-11, 2016. Hosted by Ohio's ... Convention Center. , As the longest running and largest worker's compensation event ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... Drive, Jacksonville, FL 32224, February 26th: Amateur & Professional Divisions - Time: ... Time: 7:00pm – 10:00pm | Ticket Prices $30, Social Media: http://www.USPoleSportsFed.org ...
Breaking Medicine News(10 mins):